164 related articles for article (PubMed ID: 28122407)
1. Effects of LATISSE (bimatoprost 0.03 per cent topical solution) on the ocular surface.
Bitton E; Courey C; Giancola P; Diaconu V; Wise J; Wittich W
Clin Exp Optom; 2017 Nov; 100(6):583-589. PubMed ID: 28122407
[TBL] [Abstract][Full Text] [Related]
2. Bimatoprost in the treatment of eyelash hypotrichosis.
Law SK
Clin Ophthalmol; 2010 Apr; 4():349-58. PubMed ID: 20463804
[TBL] [Abstract][Full Text] [Related]
3. Latisse (bimatoprost) for enhancement of eyelashes.
Flaharty PM; Flaharty KK; Gorman L
Insight; 2014; 39(3):24-6. PubMed ID: 25195339
[No Abstract] [Full Text] [Related]
4. Management of hypotrichosis of the eyelashes: focus on bimatoprost.
Fagien S
Plast Surg Nurs; 2015; 35(2):82-91. PubMed ID: 26020474
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes of bimatoprost for eyelash growth: results from a randomized, double-masked, vehicle-controlled, parallel-group study.
Fagien S; Walt JG; Carruthers J; Cox SE; Wirta D; Weng E; Beddingfield FC
Aesthet Surg J; 2013 Aug; 33(6):789-98. PubMed ID: 23873891
[TBL] [Abstract][Full Text] [Related]
6. Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
Med Lett Drugs Ther; 2009 Jun; 51(1313):43-4. PubMed ID: 19478690
[No Abstract] [Full Text] [Related]
7. Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease.
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clin Exp Ophthalmol; 2015 Apr; 43(3):214-20. PubMed ID: 25196488
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of trichotillomania with bimatoprost.
Peabody T; Reitz S; Smith J; Teti B
Optom Vis Sci; 2013 Jun; 90(6):e167-71. PubMed ID: 23645373
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of bimatoprost solution 0·03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Glaser DA; Hossain P; Perkins W; Griffiths T; Ahluwalia G; Weng E; Beddingfield FC
Br J Dermatol; 2015; 172(5):1384-94. PubMed ID: 25296533
[TBL] [Abstract][Full Text] [Related]
10. Eyelash growth from application of bimatoprost in gel suspension to the base of the eyelashes.
Wester ST; Lee WW; Shi W
Ophthalmology; 2010 May; 117(5):1024-31. PubMed ID: 20163864
[TBL] [Abstract][Full Text] [Related]
11. Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth.
Yoelin S; Walt JG; Earl M
Dermatol Surg; 2010 May; 36(5):638-49. PubMed ID: 20384751
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the Safety of Prostaglandin Analog Eyelash Growth Products.
Steinsapir KD; Steinsapir SMG
Dermatol Surg; 2021 May; 47(5):658-665. PubMed ID: 33625141
[TBL] [Abstract][Full Text] [Related]
13. Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study.
Brandt JD; Sall K; DuBiner H; Benza R; Alster Y; Walker G; Semba CP;
Ophthalmology; 2016 Aug; 123(8):1685-1694. PubMed ID: 27157843
[TBL] [Abstract][Full Text] [Related]
14. Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.
Sira M; Verity DH; Malhotra R
Aesthet Surg J; 2012 Sep; 32(7):822-4. PubMed ID: 22942109
[TBL] [Abstract][Full Text] [Related]
15. Management of hypotrichosis of the eyelashes: Focus on bimatoprost.
Fagien S
Clin Cosmet Investig Dermatol; 2010 Apr; 3():39-48. PubMed ID: 21437058
[TBL] [Abstract][Full Text] [Related]
16. Latisse: empirical discovery yields treatment for sparse eyelashes.
Woodson SA
Nurs Womens Health; 2009 Jun; 13(3):243-8. PubMed ID: 19523139
[No Abstract] [Full Text] [Related]
17. Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia.
Barrón-Hernández YL; Tosti A
Expert Opin Investig Drugs; 2017 Apr; 26(4):515-522. PubMed ID: 28264599
[TBL] [Abstract][Full Text] [Related]
18. Tear film osmolarity in patients treated for glaucoma or ocular hypertension.
Labbé A; Terry O; Brasnu E; Van Went C; Baudouin C
Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
[TBL] [Abstract][Full Text] [Related]
20. Bimatoprost-induced chemical blepharoplasty.
Sarnoff DS; Gotkin RH
J Drugs Dermatol; 2015 May; 14(5):472-7. PubMed ID: 25942665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
